Traditional treatments for AD, such as cholinesterase inhibitors and NMDA receptor antagonists, offer only modest symptomatic relief, while L-DOPA for PD primarily addresses motor symptoms, with limited efficacy against non-motor dysfunctions and progression
Disruptions in GSH synthesis and changes in the GSH/GSSG ratio are common for many pathological conditions, including malignant neoplasms
Drugs 75, 157174
Studies demonstrate that the peptide has the potential to slow down disease processes and to extend human lifespan
Decreased leptin levels in antisocial personality disorder patients
STEP-HFpEF Trial Committees and Investigators, Kosiborod MN, Abildstrm SZ, Borlaug BA, Butler J, Rasmussen S, Davies M et al (2023) Semaglutide in patients with heart failure with preserved ejection fraction and obesity